Open access · OA
via OpenAlex
Measures of Biologic Age in a Community Sample Predict Mortality and Age-Related Disease: The Framingham Offspring Study
Joanne M. Murabito, Qiang Zhao, Martin G. Larson, Jian Rong, Honghuang Lin, Emelia J. Benjamin, Daniel Levy, Kathryn L. Lunetta
The Journals of Gerontology Series A · 2017 · ▲ 88 citations
Abstract
Background: We tested the association of biologic age (BA) measures constructed from different types of biomarkers with mortality and disease in a community-based sample. Methods: In Framingham Offspring participants at Exams 7 (1998-2001, mean age 62 ± 10) and 8 (2005-2008, mean age 67 ± 9), we used the Klemera-Doubal method to estimate clinical BA and inflammatory BA and computed the difference (∆age) between BA and CA. Clinical ∆age was computed at Exam 2 (1979-1983, mean age 45 ± 10). At Exam 8, we computed measures of intrinsic and extrinsic epigenetic age. Participants were followed through 2014 for outcomes. Cox proportional hazards models tested the association of each BA estimate with each outcome adjusting for covariates. Results: Sample sizes ranged from 2532 to 3417 participants. In multivariable models, each 1-year increase in clinical ∆age at Exam 2 (hazard ratio [HR] = 1.04-1.06, p < 2 × 10-16) and clinical ∆age and inflammatory ∆age at Exam 7 significantly increased the hazards of mortality and incident cardiovascular disease (HR = 1.01-1.05, p < 2 × 10-7), whereas inflammatory ∆age increased the hazards of cancer (HR = 1.01, p < .05). At Exam 8, increased clinical ∆age, inflammatory ∆age, and extrinsic epigenetic age all significantly increased the hazard of mortality (HR = 1.03-1.05, all p < .05); clinical ∆age and inflammatory ∆age increased cardiovascular disease risk (HR = 1.04-1.05, all p < .01); and clinical ∆age increased cancer risk (HR = 1.03, p < .01) when all three BA measures were included in the model. Intrinsic epigenetic age was not significantly associated with any outcome. Conclusions: Our findings suggest BA measures may be complementary in predicting risk for mortality and age-related disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/gerona/glx144
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Murabito, J.M., Zhao, Q., Larson, M.G., Rong, J., Lin, H., Benjamin, E.J., Levy, D., & Lunetta, K.L. (2017). Measures of Biologic Age in a Community Sample Predict Mortality and Age-Related Disease: The Framingham Offspring Study. <em>The Journals of Gerontology Series A</em>. https://doi.org/10.1093/gerona/glx144
Vancouver
Murabito JM, Zhao Q, Larson MG, Rong J, Lin H, Benjamin EJ, et al. Measures of Biologic Age in a Community Sample Predict Mortality and Age-Related Disease: The Framingham Offspring Study. The Journals of Gerontology Series A. 2017. doi:10.1093/gerona/glx144.
BibTeX
@article{joanne2017Measur,
title = {Measures of Biologic Age in a Community Sample Predict Mortality and Age-Related Disease: The Framingham Offspring Study},
author = {Joanne M. Murabito and Qiang Zhao and Martin G. Larson and Jian Rong and Honghuang Lin and Emelia J. Benjamin and Daniel Levy and Kathryn L. Lunetta},
journal = {The Journals of Gerontology Series A},
year = {2017},
doi = {10.1093/gerona/glx144},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Epigenetics 2022
Open access · CC-BY
Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer
Epigenetics 2025
Open access · CC-BY
GrimAge and GrimAge2 Age Acceleration effectively predict mortality risk: a retrospective cohort study
BMC Medical Genomics 2024
Open access · CC-BY
Epigenetic age acceleration is associated with blood lipid levels in a multi-ancestry sample of older U.S. adults
BMC Oral Health 2021
Open access · CC-BY
Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus
medRxiv 2023
Preprint · OA
Development and Characterization of Proteomic Aging Clocks in the Atherosclerosis Risk in Communities (ARIC) Study
Clinical Epigenetics 2025
Open access · CC-BY